Fresenius Kabi's ustekinumab biosimilar Otulfi ™ is now commercially available for both subcutaneous and intravenous formulations With this launch, Fresenius Kabi Canada's immunology biosimilar ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Director and Head of Commercial, Fresenius Kabi Biopharma, Canada. Ustekinumab is a human monoclonal antibody that targets the cytokines interleukin-12 and interleukin-23 which play an important role ...

The Indiana Pacers beat the New York Knicks 130-121 in Game 4 of the Eastern Conference Finals, and now lead the series 3-1. Colin Cowherd discusses the biggest takeaways from Game 4, including ...

The Oklahoma City Thunder beat the Minnesota Timberwolves 128-126 in a tightly contested Game 4. Colin Cowherd says that the series Is over, and that Shai Gilgeous-Alexander has separated himself ...

Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, continuously executed its strategic plan during the 2024 fiscal year. The ...

The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...

The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Fresenius Kabi will be fully responsible for the marketing of Vifor’s intravenous iron portfolio in China.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...